As the CEO and Co-Founder of AccuLine, Moshe Barel is at the forefront of innovation in the healthcare sector, leveraging over 20 years of extensive business management experience to drive transformative change in cardiology. Under his leadership, AccuLine is dedicated to its mission of preventing...
As the CEO and Co-Founder of AccuLine, Moshe Barel is at the forefront of innovation in the healthcare sector, leveraging over 20 years of extensive business management experience to drive transformative change in cardiology. Under his leadership, AccuLine is dedicated to its mission of preventing heart attacks through the development of CORA, a groundbreaking, non-invasive examination designed for the early detection of coronary artery disease. This innovative approach aims to replace traditional stress tests, which are often inaccurate and can lead to delayed diagnoses.
Moshe’s expertise in strategic planning and business development has been pivotal in navigating the complexities of the medical device industry. His hands-on experience in fundraising has enabled AccuLine to secure essential capital for research and development, ensuring the advancement of CORA from concept to clinical application. With a strong focus on team leadership, Moshe has cultivated a collaborative environment that fosters innovative R&D, empowering his team to push the boundaries of product design and healthcare solutions.
In addition to his leadership role, Moshe is actively involved in marketing management and go-to-market (GTM) strategy implementation, ensuring that AccuLine’s revolutionary technology reaches the healthcare providers and patients who need it most. His comprehensive understanding of healthcare reimbursement processes further enhances AccuLine's position in the market, facilitating smoother integration of CORA into existing healthcare frameworks. With a commitment to improving patient outcomes and a passion for advancing cardiology, Moshe Barel continues to make significant strides in the fight against heart disease, solidifying AccuLine's role as a leader in the medical device landscape.
